Production and Quality Control of High-Capacity Adenoviral Vectors

作者: G SCHIEDNER , F KREPPEL , S KOCHANEK

DOI: 10.1016/B978-012164730-8/50055-1

关键词:

摘要: Publisher Summary High-capacity adenovirus (HC-Ad) vectors have been developed to address capacity, toxicity, and immunogenicity problems of first- second-generation vectors. HC-Ad cannot be produced similar helper-independent vectors, in which most viral functions are provided from the vector. Since is a relatively large DNA virus that expresses many different protein RNA functions, it unlikely complementing cell lines can generated provide appropriate levels all “trans.” The DNA-based method described here allows for fast reliable determination three parameters with standard laboratory equipment independent or reporter gene expression. production process builds on two components; vector El-deleted helper packaging signal flanked by loxP sites serial amplifications producer cells expressing Crerecombinase. Excision results preferential genomes reduction contamination.

参考文章(17)
Susanne I. Schmid, Patrick Hearing, Cellular Components Interact with Adenovirus Type 5 Minimal DNA Packaging Domains Journal of Virology. ,vol. 72, pp. 6339- 6347 ,(1998) , 10.1128/JVI.72.8.6339-6347.1998
Pablo Umaña, Christian A. Gerdes, Daniel Stone, Julian R.E. Davis, Daniel Ward, Maria G. Castro, Pedro R. Lowenstein, Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nature Biotechnology. ,vol. 19, pp. 582- 585 ,(2001) , 10.1038/89349
Frits J. Fallaux, Abraham Bout, Ietje van der Velde, Diana J. M. van den Wollenberg, Kathleen M. Hehir, Jesse Keegan, Crys Auger, Steve J. Cramer, Hans van Ormondt, Alex J. van der Eb, Dinko Valerio, Rob C. Hoeben, New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Human Gene Therapy. ,vol. 9, pp. 1909- 1917 ,(1998) , 10.1089/HUM.1998.9.13-1909
Kiran Sakhuja, P. Seshidhar Reddy, Shanthi Ganesh, Floro Cantaniag, Scott Pattison, Paullin Limbach, Dawn B. Kayda, Michael J. Kadan, Michael Kaleko, Sheila Connelly, Optimization of the Generation and Propagation of Gutless Adenoviral Vectors Human Gene Therapy. ,vol. 14, pp. 243- 254 ,(2003) , 10.1089/10430340360535797
V. Sandig, R. Youil, A. J. Bett, L. L. Franlin, M. Oshima, D. Maione, F. Wang, M. L. Metzker, R. Savino, C. T. Caskey, Optimization of the helper-dependent adenovirus system for production and potency in vivo Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 1002- 1007 ,(2000) , 10.1073/PNAS.97.3.1002
Guang-Ping Gao, Ryan K. Engdahl, James M. Wilson, A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus. Human Gene Therapy. ,vol. 11, pp. 213- 219 ,(2000) , 10.1089/10430340050016283
Philip Ng, Cindy Beauchamp, Carole Evelegh, Robin Parks, Frank L. Graham, Development of a FLP/frt system for generating helper-dependent adenoviral vectors. Molecular Therapy. ,vol. 3, pp. 809- 815 ,(2001) , 10.1006/MTHE.2001.0323
F. L. Graham, W. C. Russell, J. Smiley, R. Nairn, Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5 Journal of General Virology. ,vol. 36, pp. 59- 72 ,(1977) , 10.1099/0022-1317-36-1-59
Donna Palmer, Philip Ng, Improved system for helper-dependent adenoviral vector production Molecular Therapy. ,vol. 8, pp. 846- 852 ,(2003) , 10.1016/J.YMTHE.2003.08.014